CINDy confirmed previous predictions of modulatory interactions, such as MYC activity modulation by the STK38, MAPK1 and CSNK2A1 proteins in B-cell lymphoma [12], but it also inferred a large number of established post-translational regulatory interactions that could not be detected by MINDy (Table S2), as well as several novel predictions. Here, CSNK2A1 is linked to B-cell non-Hodgkin lymphoma.